BCL2L11 and non-small cell lung carcinoma: BIM deletion polymorphisms have been detected in approximately 12–15% of patients with NSCLC [71,72,73]; these mutations have been described in Asian and Hispanic populations, with no cases in African American or Caucasian populations.